483Sep 8, 2021

483 Document: Amplion Clinical Communications, Inc.

Mary A. Millner, FDA Investigator Nikki S. Bryant, FDA Investigator

FDANews 483 Amplion Clinical Communications, Inc. Sep 8 2021 top

Mary A. Millner FDA Investigator Nikki S. Bryant FDA Investigator

On Sep 08, 2021, the FDA inspected Amplion Clinical Communications, Inc.'s Nashville site. Explore the inspectional observations.